Global Molecular Point-of-Care Testing Market Research Report 2026(Status and Outlook)
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions. Molecular POCT involves the use of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), to detect and identify specific genetic material or biomarkers associated with diseases or infections.Here are some key factors influencing the growth of the global molecular POCT market:Increasing demand for rapid and accurate diagnostic testing: The need for rapid and accurate diagnostic testing is driving the growth of the molecular POCT market. Molecular POCT offers advantages such as rapid turnaround time, portability, and the ability to provide accurate results at the point of care, eliminating the need for sample transportation to centralized laboratories. This is particularly beneficial in emergency and critical care settings, where timely diagnosis is crucial for effective patient management.Technological advancements in molecular diagnostics: Molecular diagnostic technologies have witnessed significant advancements in recent years, enabling the development of portable, user-friendly, and easy-to-operate molecular POCT devices. These devices offer rapid and reliable results, making them suitable for use in various healthcare settings, including hospitals, clinics, ambulatory care centers, and remote or resource-limited areas. Technological advancements continue to drive the growth of the molecular POCT market.Rising prevalence of infectious diseases: The global burden of infectious diseases, such as respiratory infections, sexually transmitted infections (STIs), and gastrointestinal infections, remains significant. Molecular POCT plays a crucial role in the rapid detection and identification of pathogens responsible for these infections. The increasing prevalence of infectious diseases, coupled with the need for early diagnosis and treatment, is boosting the demand for molecular POCT solutions.Growing focus on personalized medicine: Personalized medicine aims to tailor medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Molecular POCT plays a vital role in enabling personalized medicine by providing rapid and accurate genetic testing at the point of care. These tests help identify genetic variations, mutations, or biomarkers that can guide treatment decisions and improve patient outcomes. The growing focus on personalized medicine is driving the adoption of molecular POCT.COVID-19 pandemic impact: The ongoing COVID-19 pandemic has significantly accelerated the demand for molecular POCT. Rapid and accurate testing for SARS-CoV-2, the virus responsible for COVID-19, has been crucial in controlling the spread of the disease and managing patient care effectively. Molecular POCT devices, such as rapid antigen tests and molecular NAATs, have been widely used for COVID-19 testing in various healthcare settings. The global molecular POCT market can be segmented based on technology (PCR, NAATs, hybridization, and others), application (infectious diseases, oncology, genetics, and others), end-user (hospitals, clinics, ambulatory care centers, research institutes, and others), and geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa).In summary, the global molecular POCT market is driven by the increasing demand for rapid and accurate diagnostic testing, technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, the growing focus on personalized medicine, and the impact of the COVID-19 pandemic. Molecular POCT offers the advantage of providing rapid and accurate results at the point of care, enabling timely and appropriate patient management. The market is expected to witness significant growth as the demand for portable and user-friendly molecular diagnostic solutions continues to rise.
The global Molecular Point-of-Care Testing market size was estimated at USD 7765.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Molecular Point-of-Care Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Molecular Point-of-Care Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Point-of-Care Testing market.
Global Molecular Point-of-Care Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Molecular Diagnostics
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
bioM?rieux, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Market Segmentation (by Application)
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Point-of-Care Testing Market
Overview of the regional outlook of the Molecular Point-of-Care Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Point-of-Care Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Point-of-Care Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Molecular Point-of-Care Testing market size was estimated at USD 7765.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Molecular Point-of-Care Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Molecular Point-of-Care Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Point-of-Care Testing market.
Global Molecular Point-of-Care Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Molecular Diagnostics
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
bioM?rieux, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Market Segmentation (by Application)
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Point-of-Care Testing Market
Overview of the regional outlook of the Molecular Point-of-Care Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Point-of-Care Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Point-of-Care Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Molecular Point-of-Care Testing
1.2 Key Market Segments
1.2.1 Molecular Point-of-Care Testing Segment by Type
1.2.2 Molecular Point-of-Care Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR POINT-OF-CARE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Point-of-Care Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Molecular Point-of-Care Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR POINT-OF-CARE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Molecular Point-of-Care Testing Product Life Cycle
3.3 Global Molecular Point-of-Care Testing Sales by Manufacturers (2020-2025)
3.4 Global Molecular Point-of-Care Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Point-of-Care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Point-of-Care Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Point-of-Care Testing Market Competitive Situation and Trends
3.8.1 Molecular Point-of-Care Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Molecular Point-of-Care Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MOLECULAR POINT-OF-CARE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Point-of-Care Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR POINT-OF-CARE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Molecular Point-of-Care Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Molecular Point-of-Care Testing Market
5.7 ESG Ratings of Leading Companies
6 MOLECULAR POINT-OF-CARE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Point-of-Care Testing Sales Market Share by Type (2020-2025)
6.3 Global Molecular Point-of-Care Testing Market Size by Type (2020-2025)
6.4 Global Molecular Point-of-Care Testing Price by Type (2020-2025)
7 MOLECULAR POINT-OF-CARE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Point-of-Care Testing Market Sales by Application (2020-2025)
7.3 Global Molecular Point-of-Care Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
8 MOLECULAR POINT-OF-CARE TESTING MARKET SALES BY REGION
8.1 Global Molecular Point-of-Care Testing Sales by Region
8.1.1 Global Molecular Point-of-Care Testing Sales by Region
8.1.2 Global Molecular Point-of-Care Testing Sales Market Share by Region
8.2 Global Molecular Point-of-Care Testing Market Size by Region
8.2.1 Global Molecular Point-of-Care Testing Market Size by Region
8.2.2 Global Molecular Point-of-Care Testing Market Size by Region
8.3 North America
8.3.1 North America Molecular Point-of-Care Testing Sales by Country
8.3.2 North America Molecular Point-of-Care Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Molecular Point-of-Care Testing Sales by Country
8.4.2 Europe Molecular Point-of-Care Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Molecular Point-of-Care Testing Sales by Region
8.5.2 Asia Pacific Molecular Point-of-Care Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Molecular Point-of-Care Testing Sales by Country
8.6.2 South America Molecular Point-of-Care Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Molecular Point-of-Care Testing Sales by Region
8.7.2 Middle East and Africa Molecular Point-of-Care Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MOLECULAR POINT-OF-CARE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Molecular Point-of-Care Testing by Region(2020-2025)
9.2 Global Molecular Point-of-Care Testing Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Point-of-Care Testing Production
9.4.1 North America Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.4.2 North America Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Point-of-Care Testing Production
9.5.1 Europe Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.5.2 Europe Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Point-of-Care Testing Production (2020-2025)
9.6.1 Japan Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.6.2 Japan Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Point-of-Care Testing Production (2020-2025)
9.7.1 China Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.7.2 China Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche Molecular Diagnostics
10.1.1 Roche Molecular Diagnostics Basic Information
10.1.2 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Overview
10.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.1.4 Roche Molecular Diagnostics Business Overview
10.1.5 Roche Molecular Diagnostics SWOT Analysis
10.1.6 Roche Molecular Diagnostics Recent Developments
10.2 Roche Diagnostics
10.2.1 Roche Diagnostics Basic Information
10.2.2 Roche Diagnostics Molecular Point-of-Care Testing Product Overview
10.2.3 Roche Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.2.4 Roche Diagnostics Business Overview
10.2.5 Roche Diagnostics SWOT Analysis
10.2.6 Roche Diagnostics Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Molecular Point-of-Care Testing Product Overview
10.3.3 Abbott Laboratories Molecular Point-of-Care Testing Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Danaher Corporation
10.4.1 Danaher Corporation Basic Information
10.4.2 Danaher Corporation Molecular Point-of-Care Testing Product Overview
10.4.3 Danaher Corporation Molecular Point-of-Care Testing Product Market Performance
10.4.4 Danaher Corporation Business Overview
10.4.5 Danaher Corporation Recent Developments
10.5 bioM?rieux, Inc.
10.5.1 bioM?rieux, Inc. Basic Information
10.5.2 bioM?rieux, Inc. Molecular Point-of-Care Testing Product Overview
10.5.3 bioM?rieux, Inc. Molecular Point-of-Care Testing Product Market Performance
10.5.4 bioM?rieux, Inc. Business Overview
10.5.5 bioM?rieux, Inc. Recent Developments
10.6 Hologic, Inc.
10.6.1 Hologic, Inc. Basic Information
10.6.2 Hologic, Inc. Molecular Point-of-Care Testing Product Overview
10.6.3 Hologic, Inc. Molecular Point-of-Care Testing Product Market Performance
10.6.4 Hologic, Inc. Business Overview
10.6.5 Hologic, Inc. Recent Developments
10.7 Meridian Bioscience, Inc.
10.7.1 Meridian Bioscience, Inc. Basic Information
10.7.2 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Overview
10.7.3 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Market Performance
10.7.4 Meridian Bioscience, Inc. Business Overview
10.7.5 Meridian Bioscience, Inc. Recent Developments
10.8 Saw Diagnostics
10.8.1 Saw Diagnostics Basic Information
10.8.2 Saw Diagnostics Molecular Point-of-Care Testing Product Overview
10.8.3 Saw Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.8.4 Saw Diagnostics Business Overview
10.8.5 Saw Diagnostics Recent Developments
10.9 Siemens Healthineer
10.9.1 Siemens Healthineer Basic Information
10.9.2 Siemens Healthineer Molecular Point-of-Care Testing Product Overview
10.9.3 Siemens Healthineer Molecular Point-of-Care Testing Product Market Performance
10.9.4 Siemens Healthineer Business Overview
10.9.5 Siemens Healthineer Recent Developments
10.10 Sona Nanotech
10.10.1 Sona Nanotech Basic Information
10.10.2 Sona Nanotech Molecular Point-of-Care Testing Product Overview
10.10.3 Sona Nanotech Molecular Point-of-Care Testing Product Market Performance
10.10.4 Sona Nanotech Business Overview
10.10.5 Sona Nanotech Recent Developments
10.11 T2 Biosystems
10.11.1 T2 Biosystems Basic Information
10.11.2 T2 Biosystems Molecular Point-of-Care Testing Product Overview
10.11.3 T2 Biosystems Molecular Point-of-Care Testing Product Market Performance
10.11.4 T2 Biosystems Business Overview
10.11.5 T2 Biosystems Recent Developments
10.12 Talis Biomedical
10.12.1 Talis Biomedical Basic Information
10.12.2 Talis Biomedical Molecular Point-of-Care Testing Product Overview
10.12.3 Talis Biomedical Molecular Point-of-Care Testing Product Market Performance
10.12.4 Talis Biomedical Business Overview
10.12.5 Talis Biomedical Recent Developments
10.13 Thermo Fisher Scientific Inc.
10.13.1 Thermo Fisher Scientific Inc. Basic Information
10.13.2 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Overview
10.13.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Market Performance
10.13.4 Thermo Fisher Scientific Inc. Business Overview
10.13.5 Thermo Fisher Scientific Inc. Recent Developments
10.14 Veramarx
10.14.1 Veramarx Basic Information
10.14.2 Veramarx Molecular Point-of-Care Testing Product Overview
10.14.3 Veramarx Molecular Point-of-Care Testing Product Market Performance
10.14.4 Veramarx Business Overview
10.14.5 Veramarx Recent Developments
10.15 XCR Diagnostics
10.15.1 XCR Diagnostics Basic Information
10.15.2 XCR Diagnostics Molecular Point-of-Care Testing Product Overview
10.15.3 XCR Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.15.4 XCR Diagnostics Business Overview
10.15.5 XCR Diagnostics Recent Developments
10.16 Zhejiang Orient Gene Biotech
10.16.1 Zhejiang Orient Gene Biotech Basic Information
10.16.2 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Overview
10.16.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Market Performance
10.16.4 Zhejiang Orient Gene Biotech Business Overview
10.16.5 Zhejiang Orient Gene Biotech Recent Developments
11 MOLECULAR POINT-OF-CARE TESTING MARKET FORECAST BY REGION
11.1 Global Molecular Point-of-Care Testing Market Size Forecast
11.2 Global Molecular Point-of-Care Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Point-of-Care Testing Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Point-of-Care Testing Market Size Forecast by Region
11.2.4 South America Molecular Point-of-Care Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Molecular Point-of-Care Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Molecular Point-of-Care Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Molecular Point-of-Care Testing by Type (2026-2035)
12.1.2 Global Molecular Point-of-Care Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Molecular Point-of-Care Testing by Type (2026-2035)
12.2 Global Molecular Point-of-Care Testing Market Forecast by Application (2026-2035)
12.2.1 Global Molecular Point-of-Care Testing Sales (K Units) Forecast by Application
12.2.2 Global Molecular Point-of-Care Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Molecular Point-of-Care Testing
1.2 Key Market Segments
1.2.1 Molecular Point-of-Care Testing Segment by Type
1.2.2 Molecular Point-of-Care Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR POINT-OF-CARE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Point-of-Care Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Molecular Point-of-Care Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR POINT-OF-CARE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Molecular Point-of-Care Testing Product Life Cycle
3.3 Global Molecular Point-of-Care Testing Sales by Manufacturers (2020-2025)
3.4 Global Molecular Point-of-Care Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Point-of-Care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Point-of-Care Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Point-of-Care Testing Market Competitive Situation and Trends
3.8.1 Molecular Point-of-Care Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Molecular Point-of-Care Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MOLECULAR POINT-OF-CARE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Point-of-Care Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR POINT-OF-CARE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Molecular Point-of-Care Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Molecular Point-of-Care Testing Market
5.7 ESG Ratings of Leading Companies
6 MOLECULAR POINT-OF-CARE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Point-of-Care Testing Sales Market Share by Type (2020-2025)
6.3 Global Molecular Point-of-Care Testing Market Size by Type (2020-2025)
6.4 Global Molecular Point-of-Care Testing Price by Type (2020-2025)
7 MOLECULAR POINT-OF-CARE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Point-of-Care Testing Market Sales by Application (2020-2025)
7.3 Global Molecular Point-of-Care Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
8 MOLECULAR POINT-OF-CARE TESTING MARKET SALES BY REGION
8.1 Global Molecular Point-of-Care Testing Sales by Region
8.1.1 Global Molecular Point-of-Care Testing Sales by Region
8.1.2 Global Molecular Point-of-Care Testing Sales Market Share by Region
8.2 Global Molecular Point-of-Care Testing Market Size by Region
8.2.1 Global Molecular Point-of-Care Testing Market Size by Region
8.2.2 Global Molecular Point-of-Care Testing Market Size by Region
8.3 North America
8.3.1 North America Molecular Point-of-Care Testing Sales by Country
8.3.2 North America Molecular Point-of-Care Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Molecular Point-of-Care Testing Sales by Country
8.4.2 Europe Molecular Point-of-Care Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Molecular Point-of-Care Testing Sales by Region
8.5.2 Asia Pacific Molecular Point-of-Care Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Molecular Point-of-Care Testing Sales by Country
8.6.2 South America Molecular Point-of-Care Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Molecular Point-of-Care Testing Sales by Region
8.7.2 Middle East and Africa Molecular Point-of-Care Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MOLECULAR POINT-OF-CARE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Molecular Point-of-Care Testing by Region(2020-2025)
9.2 Global Molecular Point-of-Care Testing Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Point-of-Care Testing Production
9.4.1 North America Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.4.2 North America Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Point-of-Care Testing Production
9.5.1 Europe Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.5.2 Europe Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Point-of-Care Testing Production (2020-2025)
9.6.1 Japan Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.6.2 Japan Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Point-of-Care Testing Production (2020-2025)
9.7.1 China Molecular Point-of-Care Testing Production Growth Rate (2020-2025)
9.7.2 China Molecular Point-of-Care Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche Molecular Diagnostics
10.1.1 Roche Molecular Diagnostics Basic Information
10.1.2 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Overview
10.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.1.4 Roche Molecular Diagnostics Business Overview
10.1.5 Roche Molecular Diagnostics SWOT Analysis
10.1.6 Roche Molecular Diagnostics Recent Developments
10.2 Roche Diagnostics
10.2.1 Roche Diagnostics Basic Information
10.2.2 Roche Diagnostics Molecular Point-of-Care Testing Product Overview
10.2.3 Roche Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.2.4 Roche Diagnostics Business Overview
10.2.5 Roche Diagnostics SWOT Analysis
10.2.6 Roche Diagnostics Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Molecular Point-of-Care Testing Product Overview
10.3.3 Abbott Laboratories Molecular Point-of-Care Testing Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Danaher Corporation
10.4.1 Danaher Corporation Basic Information
10.4.2 Danaher Corporation Molecular Point-of-Care Testing Product Overview
10.4.3 Danaher Corporation Molecular Point-of-Care Testing Product Market Performance
10.4.4 Danaher Corporation Business Overview
10.4.5 Danaher Corporation Recent Developments
10.5 bioM?rieux, Inc.
10.5.1 bioM?rieux, Inc. Basic Information
10.5.2 bioM?rieux, Inc. Molecular Point-of-Care Testing Product Overview
10.5.3 bioM?rieux, Inc. Molecular Point-of-Care Testing Product Market Performance
10.5.4 bioM?rieux, Inc. Business Overview
10.5.5 bioM?rieux, Inc. Recent Developments
10.6 Hologic, Inc.
10.6.1 Hologic, Inc. Basic Information
10.6.2 Hologic, Inc. Molecular Point-of-Care Testing Product Overview
10.6.3 Hologic, Inc. Molecular Point-of-Care Testing Product Market Performance
10.6.4 Hologic, Inc. Business Overview
10.6.5 Hologic, Inc. Recent Developments
10.7 Meridian Bioscience, Inc.
10.7.1 Meridian Bioscience, Inc. Basic Information
10.7.2 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Overview
10.7.3 Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Market Performance
10.7.4 Meridian Bioscience, Inc. Business Overview
10.7.5 Meridian Bioscience, Inc. Recent Developments
10.8 Saw Diagnostics
10.8.1 Saw Diagnostics Basic Information
10.8.2 Saw Diagnostics Molecular Point-of-Care Testing Product Overview
10.8.3 Saw Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.8.4 Saw Diagnostics Business Overview
10.8.5 Saw Diagnostics Recent Developments
10.9 Siemens Healthineer
10.9.1 Siemens Healthineer Basic Information
10.9.2 Siemens Healthineer Molecular Point-of-Care Testing Product Overview
10.9.3 Siemens Healthineer Molecular Point-of-Care Testing Product Market Performance
10.9.4 Siemens Healthineer Business Overview
10.9.5 Siemens Healthineer Recent Developments
10.10 Sona Nanotech
10.10.1 Sona Nanotech Basic Information
10.10.2 Sona Nanotech Molecular Point-of-Care Testing Product Overview
10.10.3 Sona Nanotech Molecular Point-of-Care Testing Product Market Performance
10.10.4 Sona Nanotech Business Overview
10.10.5 Sona Nanotech Recent Developments
10.11 T2 Biosystems
10.11.1 T2 Biosystems Basic Information
10.11.2 T2 Biosystems Molecular Point-of-Care Testing Product Overview
10.11.3 T2 Biosystems Molecular Point-of-Care Testing Product Market Performance
10.11.4 T2 Biosystems Business Overview
10.11.5 T2 Biosystems Recent Developments
10.12 Talis Biomedical
10.12.1 Talis Biomedical Basic Information
10.12.2 Talis Biomedical Molecular Point-of-Care Testing Product Overview
10.12.3 Talis Biomedical Molecular Point-of-Care Testing Product Market Performance
10.12.4 Talis Biomedical Business Overview
10.12.5 Talis Biomedical Recent Developments
10.13 Thermo Fisher Scientific Inc.
10.13.1 Thermo Fisher Scientific Inc. Basic Information
10.13.2 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Overview
10.13.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Market Performance
10.13.4 Thermo Fisher Scientific Inc. Business Overview
10.13.5 Thermo Fisher Scientific Inc. Recent Developments
10.14 Veramarx
10.14.1 Veramarx Basic Information
10.14.2 Veramarx Molecular Point-of-Care Testing Product Overview
10.14.3 Veramarx Molecular Point-of-Care Testing Product Market Performance
10.14.4 Veramarx Business Overview
10.14.5 Veramarx Recent Developments
10.15 XCR Diagnostics
10.15.1 XCR Diagnostics Basic Information
10.15.2 XCR Diagnostics Molecular Point-of-Care Testing Product Overview
10.15.3 XCR Diagnostics Molecular Point-of-Care Testing Product Market Performance
10.15.4 XCR Diagnostics Business Overview
10.15.5 XCR Diagnostics Recent Developments
10.16 Zhejiang Orient Gene Biotech
10.16.1 Zhejiang Orient Gene Biotech Basic Information
10.16.2 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Overview
10.16.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Market Performance
10.16.4 Zhejiang Orient Gene Biotech Business Overview
10.16.5 Zhejiang Orient Gene Biotech Recent Developments
11 MOLECULAR POINT-OF-CARE TESTING MARKET FORECAST BY REGION
11.1 Global Molecular Point-of-Care Testing Market Size Forecast
11.2 Global Molecular Point-of-Care Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Point-of-Care Testing Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Point-of-Care Testing Market Size Forecast by Region
11.2.4 South America Molecular Point-of-Care Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Molecular Point-of-Care Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Molecular Point-of-Care Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Molecular Point-of-Care Testing by Type (2026-2035)
12.1.2 Global Molecular Point-of-Care Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Molecular Point-of-Care Testing by Type (2026-2035)
12.2 Global Molecular Point-of-Care Testing Market Forecast by Application (2026-2035)
12.2.1 Global Molecular Point-of-Care Testing Sales (K Units) Forecast by Application
12.2.2 Global Molecular Point-of-Care Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Point-of-Care Testing Market Size by Type (M USD)
Table 4. Global Molecular Point-of-Care Testing Market Size by Application
Table 5. Molecular Point-of-Care Testing Market Size Comparison by Region (M USD)
Table 6. Global Molecular Point-of-Care Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Point-of-Care Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Point-of-Care Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Point-of-Care Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point-of-Care Testing as of 2025)
Table 11. Global Market Molecular Point-of-Care Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Molecular Point-of-Care Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Point-of-Care Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Molecular Point-of-Care Testing Sales by Type (K Units)
Table 27. Global Molecular Point-of-Care Testing Market Size by Type (M USD)
Table 28. Global Molecular Point-of-Care Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Molecular Point-of-Care Testing Sales Market Share by Type (2020-2025)
Table 30. Global Molecular Point-of-Care Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Molecular Point-of-Care Testing Market Share by Type (2020-2025)
Table 32. Global Molecular Point-of-Care Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Molecular Point-of-Care Testing Sales (K Units) by Application
Table 34. Global Molecular Point-of-Care Testing Market Size by Application
Table 35. Global Molecular Point-of-Care Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Molecular Point-of-Care Testing Sales Market Share by Application (2020-2025)
Table 37. Global Molecular Point-of-Care Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Molecular Point-of-Care Testing Market Share by Application (2020-2025)
Table 39. Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Molecular Point-of-Care Testing Sales Market Share by Region (2020-2025)
Table 42. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025)
Table 44. North America Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Molecular Point-of-Care Testing Production (K Units) by Region(2020-2025)
Table 55. Global Molecular Point-of-Care Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Molecular Point-of-Care Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Molecular Diagnostics Basic Information
Table 63. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Overview
Table 64. Roche Molecular Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Molecular Diagnostics Business Overview
Table 66. Roche Molecular Diagnostics SWOT Analysis
Table 67. Roche Molecular Diagnostics Recent Developments
Table 68. Roche Diagnostics Basic Information
Table 69. Roche Diagnostics Molecular Point-of-Care Testing Product Overview
Table 70. Roche Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Diagnostics Business Overview
Table 72. Roche Diagnostics SWOT Analysis
Table 73. Roche Diagnostics Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Molecular Point-of-Care Testing Product Overview
Table 76. Abbott Laboratories Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Danaher Corporation Basic Information
Table 81. Danaher Corporation Molecular Point-of-Care Testing Product Overview
Table 82. Danaher Corporation Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Danaher Corporation Business Overview
Table 84. Danaher Corporation Recent Developments
Table 85. bioM?rieux, Inc. Basic Information
Table 86. bioM?rieux, Inc. Molecular Point-of-Care Testing Product Overview
Table 87. bioM?rieux, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. bioM?rieux, Inc. Business Overview
Table 89. bioM?rieux, Inc. Recent Developments
Table 90. Hologic, Inc. Basic Information
Table 91. Hologic, Inc. Molecular Point-of-Care Testing Product Overview
Table 92. Hologic, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hologic, Inc. Business Overview
Table 94. Hologic, Inc. Recent Developments
Table 95. Meridian Bioscience, Inc. Basic Information
Table 96. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Overview
Table 97. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Meridian Bioscience, Inc. Business Overview
Table 99. Meridian Bioscience, Inc. Recent Developments
Table 100. Saw Diagnostics Basic Information
Table 101. Saw Diagnostics Molecular Point-of-Care Testing Product Overview
Table 102. Saw Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Saw Diagnostics Business Overview
Table 104. Saw Diagnostics Recent Developments
Table 105. Siemens Healthineer Basic Information
Table 106. Siemens Healthineer Molecular Point-of-Care Testing Product Overview
Table 107. Siemens Healthineer Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Siemens Healthineer Business Overview
Table 109. Siemens Healthineer Recent Developments
Table 110. Sona Nanotech Basic Information
Table 111. Sona Nanotech Molecular Point-of-Care Testing Product Overview
Table 112. Sona Nanotech Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sona Nanotech Business Overview
Table 114. Sona Nanotech Recent Developments
Table 115. T2 Biosystems Basic Information
Table 116. T2 Biosystems Molecular Point-of-Care Testing Product Overview
Table 117. T2 Biosystems Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. T2 Biosystems Business Overview
Table 119. T2 Biosystems Recent Developments
Table 120. Talis Biomedical Basic Information
Table 121. Talis Biomedical Molecular Point-of-Care Testing Product Overview
Table 122. Talis Biomedical Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Talis Biomedical Business Overview
Table 124. Talis Biomedical Recent Developments
Table 125. Thermo Fisher Scientific Inc. Basic Information
Table 126. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Overview
Table 127. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Thermo Fisher Scientific Inc. Business Overview
Table 129. Thermo Fisher Scientific Inc. Recent Developments
Table 130. Veramarx Basic Information
Table 131. Veramarx Molecular Point-of-Care Testing Product Overview
Table 132. Veramarx Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Veramarx Business Overview
Table 134. Veramarx Recent Developments
Table 135. XCR Diagnostics Basic Information
Table 136. XCR Diagnostics Molecular Point-of-Care Testing Product Overview
Table 137. XCR Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. XCR Diagnostics Business Overview
Table 139. XCR Diagnostics Recent Developments
Table 140. Zhejiang Orient Gene Biotech Basic Information
Table 141. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Overview
Table 142. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Zhejiang Orient Gene Biotech Business Overview
Table 144. Zhejiang Orient Gene Biotech Recent Developments
Table 145. Global Molecular Point-of-Care Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Molecular Point-of-Care Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Molecular Point-of-Care Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Molecular Point-of-Care Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Molecular Point-of-Care Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Molecular Point-of-Care Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Molecular Point-of-Care Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Molecular Point-of-Care Testing Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Molecular Point-of-Care Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Point-of-Care Testing Market Size by Type (M USD)
Table 4. Global Molecular Point-of-Care Testing Market Size by Application
Table 5. Molecular Point-of-Care Testing Market Size Comparison by Region (M USD)
Table 6. Global Molecular Point-of-Care Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Point-of-Care Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Point-of-Care Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Point-of-Care Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Point-of-Care Testing as of 2025)
Table 11. Global Market Molecular Point-of-Care Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Molecular Point-of-Care Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Point-of-Care Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Molecular Point-of-Care Testing Sales by Type (K Units)
Table 27. Global Molecular Point-of-Care Testing Market Size by Type (M USD)
Table 28. Global Molecular Point-of-Care Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Molecular Point-of-Care Testing Sales Market Share by Type (2020-2025)
Table 30. Global Molecular Point-of-Care Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Molecular Point-of-Care Testing Market Share by Type (2020-2025)
Table 32. Global Molecular Point-of-Care Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Molecular Point-of-Care Testing Sales (K Units) by Application
Table 34. Global Molecular Point-of-Care Testing Market Size by Application
Table 35. Global Molecular Point-of-Care Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Molecular Point-of-Care Testing Sales Market Share by Application (2020-2025)
Table 37. Global Molecular Point-of-Care Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Molecular Point-of-Care Testing Market Share by Application (2020-2025)
Table 39. Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Molecular Point-of-Care Testing Sales Market Share by Region (2020-2025)
Table 42. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025)
Table 44. North America Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Molecular Point-of-Care Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Molecular Point-of-Care Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Molecular Point-of-Care Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Molecular Point-of-Care Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Molecular Point-of-Care Testing Production (K Units) by Region(2020-2025)
Table 55. Global Molecular Point-of-Care Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Molecular Point-of-Care Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Molecular Point-of-Care Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Molecular Diagnostics Basic Information
Table 63. Roche Molecular Diagnostics Molecular Point-of-Care Testing Product Overview
Table 64. Roche Molecular Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Molecular Diagnostics Business Overview
Table 66. Roche Molecular Diagnostics SWOT Analysis
Table 67. Roche Molecular Diagnostics Recent Developments
Table 68. Roche Diagnostics Basic Information
Table 69. Roche Diagnostics Molecular Point-of-Care Testing Product Overview
Table 70. Roche Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Diagnostics Business Overview
Table 72. Roche Diagnostics SWOT Analysis
Table 73. Roche Diagnostics Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Molecular Point-of-Care Testing Product Overview
Table 76. Abbott Laboratories Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Danaher Corporation Basic Information
Table 81. Danaher Corporation Molecular Point-of-Care Testing Product Overview
Table 82. Danaher Corporation Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Danaher Corporation Business Overview
Table 84. Danaher Corporation Recent Developments
Table 85. bioM?rieux, Inc. Basic Information
Table 86. bioM?rieux, Inc. Molecular Point-of-Care Testing Product Overview
Table 87. bioM?rieux, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. bioM?rieux, Inc. Business Overview
Table 89. bioM?rieux, Inc. Recent Developments
Table 90. Hologic, Inc. Basic Information
Table 91. Hologic, Inc. Molecular Point-of-Care Testing Product Overview
Table 92. Hologic, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hologic, Inc. Business Overview
Table 94. Hologic, Inc. Recent Developments
Table 95. Meridian Bioscience, Inc. Basic Information
Table 96. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Product Overview
Table 97. Meridian Bioscience, Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Meridian Bioscience, Inc. Business Overview
Table 99. Meridian Bioscience, Inc. Recent Developments
Table 100. Saw Diagnostics Basic Information
Table 101. Saw Diagnostics Molecular Point-of-Care Testing Product Overview
Table 102. Saw Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Saw Diagnostics Business Overview
Table 104. Saw Diagnostics Recent Developments
Table 105. Siemens Healthineer Basic Information
Table 106. Siemens Healthineer Molecular Point-of-Care Testing Product Overview
Table 107. Siemens Healthineer Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Siemens Healthineer Business Overview
Table 109. Siemens Healthineer Recent Developments
Table 110. Sona Nanotech Basic Information
Table 111. Sona Nanotech Molecular Point-of-Care Testing Product Overview
Table 112. Sona Nanotech Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sona Nanotech Business Overview
Table 114. Sona Nanotech Recent Developments
Table 115. T2 Biosystems Basic Information
Table 116. T2 Biosystems Molecular Point-of-Care Testing Product Overview
Table 117. T2 Biosystems Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. T2 Biosystems Business Overview
Table 119. T2 Biosystems Recent Developments
Table 120. Talis Biomedical Basic Information
Table 121. Talis Biomedical Molecular Point-of-Care Testing Product Overview
Table 122. Talis Biomedical Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Talis Biomedical Business Overview
Table 124. Talis Biomedical Recent Developments
Table 125. Thermo Fisher Scientific Inc. Basic Information
Table 126. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Product Overview
Table 127. Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Thermo Fisher Scientific Inc. Business Overview
Table 129. Thermo Fisher Scientific Inc. Recent Developments
Table 130. Veramarx Basic Information
Table 131. Veramarx Molecular Point-of-Care Testing Product Overview
Table 132. Veramarx Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Veramarx Business Overview
Table 134. Veramarx Recent Developments
Table 135. XCR Diagnostics Basic Information
Table 136. XCR Diagnostics Molecular Point-of-Care Testing Product Overview
Table 137. XCR Diagnostics Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. XCR Diagnostics Business Overview
Table 139. XCR Diagnostics Recent Developments
Table 140. Zhejiang Orient Gene Biotech Basic Information
Table 141. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Product Overview
Table 142. Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Zhejiang Orient Gene Biotech Business Overview
Table 144. Zhejiang Orient Gene Biotech Recent Developments
Table 145. Global Molecular Point-of-Care Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Molecular Point-of-Care Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Molecular Point-of-Care Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Molecular Point-of-Care Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Molecular Point-of-Care Testing Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Molecular Point-of-Care Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Molecular Point-of-Care Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Molecular Point-of-Care Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Molecular Point-of-Care Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Molecular Point-of-Care Testing Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Molecular Point-of-Care Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Molecular Point-of-Care Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Point-of-Care Testing Market Size (M USD), 2025-2035
Figure 5. Global Molecular Point-of-Care Testing Market Size (M USD) (2020-2035)
Figure 6. Global Molecular Point-of-Care Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Point-of-Care Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Point-of-Care Testing Product Life Cycle
Figure 13. Molecular Point-of-Care Testing Sales Share by Manufacturers in 2025
Figure 14. Global Molecular Point-of-Care Testing Revenue Share by Manufacturers in 2025
Figure 15. Molecular Point-of-Care Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Molecular Point-of-Care Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Point-of-Care Testing Revenue in 2025
Figure 18. Industry Chain Map of Molecular Point-of-Care Testing
Figure 19. Global Molecular Point-of-Care Testing Market PEST Analysis
Figure 20. Global Molecular Point-of-Care Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Point-of-Care Testing Market Share by Type
Figure 27. Sales Market Share of Molecular Point-of-Care Testing by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Point-of-Care Testing by Type in 2025
Figure 29. Market Share of Molecular Point-of-Care Testing by Type (2020-2025)
Figure 30. Market Share of Molecular Point-of-Care Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Point-of-Care Testing Market Share by Application
Figure 33. Global Molecular Point-of-Care Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Point-of-Care Testing Sales Market Share by Application in 2025
Figure 35. Global Molecular Point-of-Care Testing Market Share by Application (2020-2025)
Figure 36. Global Molecular Point-of-Care Testing Market Share by Application in 2025
Figure 37. Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Point-of-Care Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025)
Figure 40. North America Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 43. North America Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 45. U.S. Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Point-of-Care Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Point-of-Care Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Point-of-Care Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Point-of-Care Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 53. Europe Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 55. Germany Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Point-of-Care Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Point-of-Care Testing Market Size by Region in 2024
Figure 68. China Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 79. South America Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 80. South America Molecular Point-of-Care Testing Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 82. Brazil Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Point-of-Care Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Point-of-Care Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Point-of-Care Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Point-of-Care Testing Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Point-of-Care Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Molecular Point-of-Care Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Molecular Point-of-Care Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Molecular Point-of-Care Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Molecular Point-of-Care Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Molecular Point-of-Care Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Molecular Point-of-Care Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Point-of-Care Testing Market Size (M USD), 2025-2035
Figure 5. Global Molecular Point-of-Care Testing Market Size (M USD) (2020-2035)
Figure 6. Global Molecular Point-of-Care Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Point-of-Care Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Point-of-Care Testing Product Life Cycle
Figure 13. Molecular Point-of-Care Testing Sales Share by Manufacturers in 2025
Figure 14. Global Molecular Point-of-Care Testing Revenue Share by Manufacturers in 2025
Figure 15. Molecular Point-of-Care Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Molecular Point-of-Care Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Point-of-Care Testing Revenue in 2025
Figure 18. Industry Chain Map of Molecular Point-of-Care Testing
Figure 19. Global Molecular Point-of-Care Testing Market PEST Analysis
Figure 20. Global Molecular Point-of-Care Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Point-of-Care Testing Market Share by Type
Figure 27. Sales Market Share of Molecular Point-of-Care Testing by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Point-of-Care Testing by Type in 2025
Figure 29. Market Share of Molecular Point-of-Care Testing by Type (2020-2025)
Figure 30. Market Share of Molecular Point-of-Care Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Point-of-Care Testing Market Share by Application
Figure 33. Global Molecular Point-of-Care Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Point-of-Care Testing Sales Market Share by Application in 2025
Figure 35. Global Molecular Point-of-Care Testing Market Share by Application (2020-2025)
Figure 36. Global Molecular Point-of-Care Testing Market Share by Application in 2025
Figure 37. Global Molecular Point-of-Care Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Point-of-Care Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Point-of-Care Testing Market Size by Region (2020-2025)
Figure 40. North America Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 43. North America Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 45. U.S. Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Point-of-Care Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Point-of-Care Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Point-of-Care Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Point-of-Care Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 53. Europe Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 55. Germany Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Point-of-Care Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Point-of-Care Testing Market Size by Region in 2024
Figure 68. China Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 79. South America Molecular Point-of-Care Testing Sales Market Share by Country in 2024
Figure 80. South America Molecular Point-of-Care Testing Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Point-of-Care Testing Market Size by Country in 2024
Figure 82. Brazil Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Point-of-Care Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Point-of-Care Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Point-of-Care Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Point-of-Care Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Point-of-Care Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Point-of-Care Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Point-of-Care Testing Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Point-of-Care Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Point-of-Care Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Molecular Point-of-Care Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Molecular Point-of-Care Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Molecular Point-of-Care Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Molecular Point-of-Care Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Molecular Point-of-Care Testing Market Share Forecast by Application (2026-2035)
